In addition, NAFLD is associated with sustained activation of lipid synthesis transcription factors such as the regulatory element-binding proteins-1/2 (SREBP1/2) that stimulated triglycerides (TGs) and cholesterol (CHOL) synthesis, respectively [8]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.